To evaluate the role of vitamin D 3 during gestation and lactation of sows, 2 independent experiments were performed with the aim of investigating sow reproductive performance, milk composition (study 1 only), and changes in blood status of 25-hydroxycholecalciferol (25-OH-D 3 ), 1,25-dihydroxycholecalciferol (1,25-(OH) 2 -D 3 ; study 2 only), minerals, and bone markers of sows during gestation and lactation. Study 1 comprised 39 primi-and multiparous crossbred sows fed 1 of 3 barley meal-based diets fortified with 200 IU/kg vitamin D 3 (NRC, 1998; treatment DL), 2,000 IU/kg vitamin D 3 (cholecalciferol; treatment DN), or 50 μg 25-OH-D 3 (calcidiol; treatment HD)/kg feed. This study was conducted over a 4-parity period under controlled conditions. Study 2, running over 1 parity only, was performed in a commercial farm with 227 primi-and multiparous sows allocated to 2 dietary treatments: control (CON), receiving 2,000 IU vitamin D 3 /kg (equivalent to 50 μg/kg) feed (114 sows), and test (HYD), supplemented with 50 μg 25-OH-D 3 /kg feed (113 sows). Blood samples of sows were collected at 84 and 110 d postcoitum and 1, 5, and 33 d postpartum (study 1) and at insemination and 28 and 80 d postinsemination as well as d 5 and 28 postpartum (study 2). Colostrum and milk samples in study 1 were obtained at 1, 9, and 33 d of lactation after oxytocin administration. Plasma 25-OH-D 3 concentrations were increased (P < 0.05) in sows receiving 25-OH-D 3 (HD and HYD) at any time of sampling whereas circulating plasma concentrations of 1,25-(OH) 2 -D 3 , Ca, and P were not affected by treatment. Milk concentrations of Ca and P were similar, but 25-OH-D 3 content (except in colostrum) was clearly increased (P < 0.05) when 25-OH-D 3 was fed. Most characteristics of sow reproductive performance responded similarly to the 2 sources and levels of vitamin D 3 , but weight gain of piglets between birth and weaning was decreased (P < 0.05) in offspring of DL and HD sows compared with animals of treatment DN (study 1). In study 2 total litter weight and birth weight per piglet were increased (P < 0.05) with 25-OH-D 3 supplementation in comparison with the control (CON). Overall, feeding sows with 25-OH-D 3 was considered to improve maternal supply with vitamin D 3 and thereby maintain Ca homeostasis during gestation and lactation.
INTRODUCTION
Vitamin D 3 is essential for regular growth and development as well as for maintenance of a normal calciumphosphate homeostasis in mammals by regulating the active intestinal absorption of those minerals required for bone mineralization (DeLuca, 1978) . During gestation and lactation, vitamin D 3 metabolism in the female is subject to increasing requirements for Ca for fetal growth and milk production . This exceptional demand is supposed to result in mobilization of Ca from the skeleton. The bone content of Ca is known to be depleted during periods of reproduction (Giesemann et al., 1998) , which causes weakness of the skeleton and leads to lameness or even bone fractures. Such problems with the musculoskeletal system are among the primary causes for culling of sows raised under commercial conditions (Kirk et al., 2005) . It is generally accepted that 10 to 15% of the culls are attributable to leg problems but figures of up to 40% have been reported (Kirk et al., 2005) . Culling sows after a short production period represents a considerable loss to the pig industry (Kirk et al., 2005; Engblom et al., 2008a,b) but is also increasingly seen as a welfare issue because lameness is associated with severe pain (Jørgensen and Jørgensen, 1998) .
The knowledge of vitamin D 3 requirements of sows under current conditions is limited and very few studies have compared different sources of vitamin D 3 in swine. In the present research, the efficacy of 2 dietary sources of vitamin D 3 (i.e., cholecalciferol and 25-hydroxycholecalciferol) provided either at the NRC (1998) recommendation or at the common practical level on reproductive performance as well as on plasma and milk concentrations of vitamin D 3 , minerals, and markers of bone turnover of sows was evaluated. Two experiments with sows were performed: 1 under controlled conditions over 4 consecutive reproductive cycles (study 1) and 1 on a commercial farm over 1 reproductive cycle (study 2).
MATERIALS AND METHODS

Experimental Design: Study 1
This study was performed on the research farm Chamau (Hünenberg, Switzerland) of the Swiss Federal Institute of Technology, Zurich; the experimental use of animals and procedures applied were approved by the Committee for Animal Care and Use of Kanton Zug. Thirty-nine primiparous and multiparous crossbred sows of predominantly Large White breeding were randomly allotted to 3 dietary treatments on the day of mating and were kept on those treatments for 4 reproductive cycles. Mixed groups of 4 to 6 animals of all treatment entered the trial staggered in intervals of 21 d. The sows were kept in 1 large herd during gestation and fed individually with a computerized feeding system (Schauer Compident VI, Prambachkirchen, Austria), which was located in a pen and recorded feed intake and body weight daily. At 110 d postcoitum, pregnant dams were placed in individual farrowing pens that contained straw as bedding and heated nests for the piglets according to Swiss animal welfare guidelines. Two different types of basal sow diets (gestation and lactation), with barley, corn, wheat, and soybean meal as main ingredients, were used in the present experiment. The gestation diet was fed from mating until d 110 of gestation followed by the lactation diet, which was provided throughout the lactation period until weaning on d 35 postpartum (PP). The diets were offered in a pelleted form twice daily during both gestation (2.2 to 2.5 kg/d) and lactation (5.2 to 5.6 kg/d), depending on the requirements of the individual animal. The composition of the diets as well as the analyzed nutrient content is given in Table 1 . During both gestation and lactation, animals had free access to water. At breeding, the sows were randomly allotted to 1 of 3 experimental treatments. The diet of treatment (DL) was supplemented with 200 IU cholecalciferol (vitamin D 3 ; ROVIMIX D3-500; DSM Nutritional Products, Basel, Switzerland)/kg feed, representing the minimum level according to recommendations of the NRC (1998). The diet for treatment (DN) was fortified with 2,000 IU vitamin D 3 /kg feed (ROVIMIX D3-500; equivalent to 50 μg/kg feed), corresponding to the level used commercially in Switzerland (Boltshauser et al., 1993) and for treatment (HD) with 50 μg 25-hydroxycholecalciferol (25-OH-D3; ROVIMIX Hy-D 1.25%; DSM Nutritional Products)/kg feed. Considering the substantial variability of the analytical method, feed analysis confirmed the correct mixing of the test products ductive cycle, 10 mL of plasma and 10 mL of EDTAstabilized whole-blood samples were collected from the external jugular vein of each dam. Blood was centrifuged (3,500 × g for 15 min at 4°C) and plasma was harvested, frozen (-80°C) , and analyzed at a later time for 25-OH-D 3 , Ca, P, crosslaps (CL), and osteocalcin (OC). Within 24 h after parturition, a 100-mL sample of colostrum was collected by hand milking from every functional mammary gland after intramuscular injection with 1.5 mL oxytocin (LongActon; Vital AG, Oberentfelden, Switzerland). Further milk samples were collected in the same manner at 9 and 33 d PP.
Colostrum and milk samples were frozen at -80°C and analyzed later for 25-OH-D 3 , Ca, and P. Colostrum and milk samples were only collected in parities 1, 2, and 3.
Experimental Design: Study 2
This study was performed at the pig farm "Sauenzucht Kölsa" in Kölsa (Germany), which housed approximately 2,000 sows. The multiparous sows belonged to a local breed (LeiCoMa) and the primiparous sows were coming from the farm's own breeding stock. A total of 227 primiparous and multiparous sows were used for this trial: the control group contained 114 animals (32 primiparous and 82 multiparous sows) and the test group 113 animals (28 primiparous and 85 multiparous sows). The sows were allocated to 1 of 2 treatments: control (CON . All sows, inseminated within 1 wk, were allocated to a single treatment group (first week: CON and second week: HYD), so that after 2 wk all sows had been enrolled in the study. The sows were housed in single stands with slatted flooring during early pregnancy (1 to 85 d), flat decks with slatted flooring during late pregnancy (85 to 110 d), and farrowing decks with slatted flooring during farrowing and lactation (110 to 140 d). Temperature on the farm was kept between 20 and 25°C through heating, but humidity was not controlled.
During early pregnancy, all sows receiving the same treatment were kept in 1 room and were given the same feed in a common trough, which later in the day was used to supply drinking water. The feed was provided dry in mash form. During late pregnancy, the sows were given liquid feed in a common trough. The dry feed from the silo was suspended in water and released directly into the feeding trough. Drinking water was supplied separately. The farrowing decks were all supplied with feed from 1 silo only. This feed contained vitamin D 3 and was given to the control (i.e., CON) animals while the feed containing 25-OH-D 3 (i.e., HYD) was added by hand to the feeders of the test group.
Three feeds were used on this farm: 1) feed for early pregnancy (dry), 2) feed for late pregnancy (same composition as 1 but liquid), and 3) lactation feed. The basal feeds contained wheat, barley, soybean meal, and sorghum as main ingredients, but the exact diet composition was not disclosed by the farm. Feed analysis revealed the following compositions: feeds 1 and 2: ME = 12.1 to 12.3 MJ/kg, DM = 88.2%, CP = 136 to 143 g/kg DM, crude fiber = 56 to 57 g/kg DM, crude fat = 32 to 34 g/kg DM, Ca = 6.0 to 6.2 g/kg DM, and P = 6.1 to.6.5 g/kg DM and feed 3: ME = 13.2 to 13.3 MJ/kg, DM = 88.8 to 89.2%, CP = 179 to 180 g/kg DM, crude fiber = 40 to 41 g/kg DM, crude fat = 45 to 46 g/kg DM, Ca = 8.2 to 8.4 g/kg DM, and P = 5.5 to 6.0 g/kg DM. A pooled sample of each experimental feed was analyzed for the presence of the 2 vitamin D 3 sources (CON: vitamin D 3 = 2.460 IU/kg and 25-OH-D 3 = below detection limit; HYD: vitamin D 3 = 890 IU/kg and 25-OH-D 3 = 42.6 μg/kg).
Related to reproductive characteristics the percentage of pregnant sows, the number and weight of piglets born (alive, or dead), and the total weight of weaned piglets were determined. Blood samples were taken by venipuncture of the vena cava cranialis on the day of AI, 28 and 80 d postinsemination, and on d 5 and 28 PP from 25 sows of each treatment group. The concentrations of the vitamin D 3 metabolites 25-OH-D 3 , 1,25-dihydroxycholecalciferol (1,25-(OH) 2 -D 3 ), Ca, and P as well as the concentration of the bone markers OC and CL were determined in blood plasma. Due to sows dying or being culled during the experiment or insufficient sample size, not all planned analyses could be performed.
Analytical Methods
Determination of 25-OH-D 3 in plasma and feed samples was performed by DSM Nutritional Products. The method was based on an isotope dilution assay using an Agilent 1100 reversed-phase HPLCmass spectrometry system (Basel, Switzerland) with a trapping column for quantification. In colostrum and milk samples, 25-OH-D 3 concentration was analyzed using a RIA kit (25-Hydroxy Vitamin D; IDS Immunodiagnostic Systems Ltd., Boldon, Tyne, and Wear, UK). Blood concentration of 1,25-(OH) 2 -D 3 was determined from 250 μL plasma using a commercial RIA (1,25-dihydroxy Vitamin D RIA, catalog number AA-54; Immunodiagnostic Systems). The assay comprised an immune extraction for purification and an enrichment of 1,25-(OH) 2 -D 3 followed by RIA with 125 I as tracer. Calcium and P in plasma were determined by colorimetry with a UV-visible recording spectrophotometer (UV-160A; Shimadzu Corporation, Kyoto, Japan) using commercial kits (Axon Lab AG, Baden, Switzerland). Analyses were based on the methylthy-mol blue method for Ca (Gindler and King, 1972) and the phosphomolybdate method for P (Quadri and Srivastava, 1980) . Plasma concentrations of OC and CL were measured using commercially available ELISA test kits (Metra OC; Quidel Corporation, San Diego, CA; Crosslaps; IDS Immunodiagnostic Systems Ltd.). For the determination of milk mineral content, the samples were prepared according to the method described by Park et al. (1994) and then Ca and P were measured as in plasma samples.
Statistical Analysis
Statistical analysis for study 1 was performed using the generalized least squares procedure (GLS) of R 2.8.1 (Venables et al., 2006) with treatment and parity as main effects. Values in tables represent means and the maximum SEM is stated. When significant (P < 0.05) dependent variable effects were found, mean values were separated using Wilcoxon's sign rank test.
Statistical analyses for study 2 were performed with the statistical software R, version 3.0.1 (Venables et al., 2006) using additional packages nlme (version 3.1-109 [Pinheiro et al., 2013] ) and car (version 2.0-18 [Fox and Weisberg, 2011] ). All blood characteristics (except 1,25-(OH) 2 -D 3 ) were log-transformed to base 10 because their distributions were skewed. To investigate the effect of the supplementation, a linear mixed-effects model with the fixed-effects treatment group, sampling time point (as factor), treatment × time interaction, and the random effect animal was used. The reported treatment × time point interaction P-values describe the additional influence of the supplementation at the respective time point adjusted for baseline differences between groups and accounting for multiple measurements per sow. Fertility analyses were done using the exact Fisher test for proportions, ANOVA (adjusted for lactation period), and Poisson regression (adjusted for lactation period). A P-value of ≤0.05 was considered significant whereas a P-value ≤0.10 but >0.05 was taken as an indication for a near-significant trend.
RESULTS
Blood Characteristics of Sows: Study 1
The effects of treatment on plasma 25-OH-D 3 levels at the various measurement periods are presented in Fig. 1 . Animals on diet HD had increased (P < 0.05) 25-OH-D 3 plasma concentrations (between +40.5% in parity 3 [d 5 PP] and 332% in parity 1 [d 33 PP]) over the DL-group at any time of sampling while HD did not differ statistically from the DN group. Concentrations reached their maximum immediately before parturition and decreased during the course of lactation. In treatment groups DL and DN, the least plasma levels of 25-OH-D 3 were found at weaning whereas levels in HD animals were increasing again after the first week of lactation to the level of the PP samples.
Regarding circulating concentrations of Ca in plasma of sows at the various time points of measurement (Fig. 2) , differences (P < 0.05) between treatments oc- curred only on d 84 of gestation during parity 3, where levels of Ca in the DN group decreased significantly by 17.4% compared with the DL group. In all treatment groups, there was a decrease in circulating levels of Ca during gestation and a subsequent increase after farrowing, which lasted until midlactation. Over time, a decline in plasma Ca levels between parity 1 and 4 was observed. Plasma P concentrations were similar between treatments (Fig. 3) . Only at d 110 of gestation in parity 1, circulating P levels were greater by 15.1 and 17.2%, respectively (P < 0.05), in DN and HD sows than in the DL-group. Common to all treatment groups, P concentrations clearly declined with advancing parity. Mean OC concentrations did not differ between treatments at any point of sampling, but a decline was observed throughout gestation in all treatment groups followed by an increase in the subsequent lactation (Fig. 4) .
Over time, there was a general decrease in plasma OC concentrations from parity 1 to 4. The course of the curve of the circulating CL concentrations was similar for all treatment groups with a drop at birth followed by a more or less pronounced increase during lactation (Fig. 5) . On d 1 of parity 4, a significant decrease of CL by 11.1% (P < 0.05) was observed in HD sows in comparison to DL.
Vitamin D Concentration of Colostrum and Milk: Study 1
The supplementation of 25-OH-D 3 clearly affected 25-OH-D 3 concentrations in milk (Fig. 6 ). In the first parity, colostrum 25-OH-D 3 concentration was greatest (P < 0.05) in samples of HD animals (12.3% above DL) whereas 25-OH-D 3 concentrations in colostrum of the following parities did not differ between treatment groups. Later milk samples of HD sows contained between 42.4 25-(OH) 2 -D 3 ) , the bone markers crosslaps and osteocalcin, and the minerals calcium and phosphorus in plasma of sows in study 2 (means ± SD). Results of the statistical analyses as described in the text are reported as P-values. and 129% more (P < 0.05) 25-OH-D 3 than those from DL and DN animals in parities 2 and 3 but not in parity 1. There was no effect of dietary treatment on Ca concentrations of colostrum and milk, but contents generally increased from the start of lactation to weaning (Fig. 7 ). Concentrations of P were similar at the various sampling times except for d 9 of lactation in parity 3, where samples of DN sows contained significantly more (+29.5%) of that mineral (P < 0.05; Fig. 8 ) than the DL sows.
Reproductive and Litter Performance: Study 1
The main effects of treatment and parity on parturition and litter performance are reported in Table 2 . Mean litter number between the groups was similar and treatment had no effect on the number of piglets born, the number of stillborn piglets, or on litter weight at birth. At weaning, litter gain, loss of piglets during the suckling period, and individual pig weight were not affected by vitamin D source and level whereas there was a trend (P = 0.10) towards a smaller number of piglets weaned in treatment HD. Weight gain of the suckling piglets, however, was greatest (P < 0.01) when diet DN was provided. The number of piglets born, the number of piglets weaned, and weight gains of individual piglets and litters increased (P < 0.05) with advancing parity of dams.
Blood Characteristics of Sows: Study 2
Supplementation of the diet with 25-OH-D 3 (HYD) resulted in an increase (P < 0.05) in this vitamin D 3 metabolite in blood by 36.5 to 177.4% compared with the CON-group (Table 3) but did not influence the concentration of 1,25-(OH) 2 -D 3 during pregnancy. In both groups, the plasma concentration of 1,25-(OH) 2 -D 3 increased before parturition to almost the same extent (Table 3). Yet 5 d PP the concentration of 1,25-(OH) 2 -D 3 was significantly greater in treatment HYD compared with CON (P < 0.05) whereas on d 28 PP no difference among the treatments was observed again.
The plasma concentrations of Ca and P varied little during pregnancy and lactation and did not differ between the 2 treatment groups, except on d 5 PP, where Ca was less in the HYD than in the CON group (P = 0.028; Table 3 ). The plasma levels of OC showed considerable variations, but no consistent differences between the treatments were recorded. In both groups, there was a trend of a reduction of OC levels during parturition to decrease at 5 d PP and then to increase to the end of lactation (28 d PP). The CL concentrations increased in both treatments subsequent to parturition and were greatest at the end of lactation. The plasma levels of CL were reduced (P = 0.01) in the HYD group at insemination and tended to be reduced (P = 0.10) during early lactation (5 d PP), but CL concentration was greater (P = 0.001) in HYD pigs during late pregnancy in comparison with CON pigs (80 d postinsemination; Table 3 ). 
Reproductive and Litter Performance: Study 2
From 114 sows of the CON-group that were artificially inseminated, 89% became pregnant and 78% eventually farrowed (Table 4 ). In the HYD group, 92% of 113 inseminated sows became pregnant and 82% of them farrowed. These proportions were not different between the 2 treatments. Although the absolute number of piglets born alive and of piglets weaned was numerically greater in the HYD group, the proportion of piglets born alive that were weaned was less (P = 0.03) in HYD when compared with CON, due to a trend of a greater (P = 0.077) proportion of lost piglets to piglets born alive. However, the total litter weight (P = 0.027) as well as the birth weight per piglet (P = 0.008) was greater than the control (CON) in the supplemented group (HYD; Table 4 ).
DISCUSSION
The aim of the present studies was to investigate the vitamin D 3 requirements of sows under current husbandry conditions and to compare supplementation of vitamin D 3 with 25-OH-D 3 in swine. Using different sources and levels of vitamin D 3 did not strongly affect any maternal plasma measurement except 25-OH-D 3 . Circulating 25-OH-D 3 levels are known to be directly related to dietary vitamin D 3 intake (Hollis and Wagner, 2006) and, therefore, regarded as a good index of nutritional vitamin D 3 status (Salle et al., 2000) . Plasma 25-OH-D 3 levels of sows in both studies showed greatest concentrations in animals receiving 25-OH-D 3 as the vitamin D 3 source. As reported by Horst and Littledike (1982) , 25-OH-D 3 circulates in most species at 30 to 50 ng/mL. In study 1, plasma concentrations of DN and DL animals were found within that range whereas circulating levels of 25-OH-D 3 in HD sows exceeded that range at any time of sampling due to dietary 25-OH-D 3 administration. In the more practical study 2, all 25-OH-D 3 concentrations were considerably less with levels from 11.6 to 22.6 ng/mL in the CON and 23.0 to 48.0 ng/mL in the HYD group. For humans, Holick (2007) considered 25-OH-D 3 plasma levels below 20 ng/mL as insufficient and over 30 ng/mL as adequate. Assuming a similar situation in swine, the CON sows in the commercial farm were deficient in vitamin D 3 although they received 2,000 IU vitamin D 3 /kg feed, which represents the maximum legal dietary vitamin D 3 level in the European Union. Only the HYD animals, which were supplemented with 25-OH-D 3 via the feed, were sufficiently supplied with vitamin D 3 activity. Hughes et al. (1977) reported that hydroxylation of 25-OH-D 3 to 1,25-(OH) 2 -D 3 , the active form of vitamin D 3 , was not enhanced by increasing the dietary intake of vitamin D 3 , but it was rather limited by the availability of its substrate. It seems likely that increasing Ca demand during pregnancy and lactation should result in greater requirements for the precursor of 1,25-hydroxylation and, thus, may cause a decrease in plasma 25-OH-D 3 . In this respect the observation of a significantly smaller 1,25-(OH) 2 -D 3 concentration during early lactation in the CON-group compared with the HYD sows in study 2 was interesting. This finding could indicate that at the onset of milk production, the demand for Ca was increased to such an extent that in CON sows not enough 25-OH-D 3 may have been available to sustain the required production of 1,25-(OH) 2 -D 3 . Furthermore, it was remarkable that, in contrast to animals of the other treatment groups, plasma 25-OH-D 3 concentration in sows supplemented with this vitamin D 3 metabolite (HD and HYD) increased already shortly after parturition and reached prepartum levels at weaning. This observation indicates that dietary 25-OH-D 3 is more read- ily available to rapidly reestablish a steady state in the sows after an exceptional demand.
In all treatments of the present studies, plasma Ca concentrations were within the normal reference range, as described by Friendship et al. (1984) and Reese et al. (1984) , and were not affected by dietary treatment. Maternal adaptations of Ca homeostasis are known to differ between pregnancy and lactation. According to Meissonier et al. (1980) and Lingaas et al. (1992) , plasma Ca of sows decreased with progressing parity, which was confirmed by Liesegang et al. (2005) and which is consistent with the observations in study 1. Likewise in the rat, plasma Ca has been reported to decrease during the last several days of pregnancy (Garner et al., 1988) . Kovacs and Kronenberg (1997) suggested that maternal losses of Ca to a litter of rapidly growing fetuses probably exceed the maternal Ca stores (Garel, 1987) . Since plasma Ca concentrations in sows on both treatments remained stable, these animals apparently absorbed enough Ca from the feed to keep a balanced mineral homeostasis.
Mean plasma P concentration in pigs varies with the amount of P available in the diet (McDowell, 1992) . Because in both studies P concentrations in plasma were found to be similar to the reference values obtained by Verheyen et al. (2007) in commercial sow herds, the diet composition was adequate for the P requirement of sows. Nevertheless, circulating concentrations of P in the present studies varied during the course of the reproductive cycle. The decrease at the beginning of lactation in most treatment groups was probably attributable to the sudden increase in P demand for milk production. The subsequent increase between d 5 of lactation and weaning (only in study 1) may be an indication of the increased skeletal resorption and decreased renal excretion (Kovacs and Kronenberg, 1997) . Furthermore, as reported by Meissonnier et al. (1980) and Girard et al. (1996) , plasma P concentrations were greater in first parity sows than in sows during later parities. It seems likely that lactation intensity, as described above, was responsible for the decrease of both plasma Ca and P.
In women, circulating levels of bone formation markers have been found to be decreased in early gestation and to rise slightly by term (Cross et al., 1995) . This was not the case in our studies where circulating OC concentrations decreased in late gestation and reached the least peak at parturition or early lactation. The subsequent increase in bone formation during lactation, however, has been described previously for women (Cross et al., 1995; Salle et al., 2000) and for sows (Liesegang et al., 2005; Verheyen et al., 2007) . Consistent with previous reports (Friendship et al., 1984; Tumbleson et al., 1986; Verheyen et al., 2007) , plasma OC concentrations were greater in first parity sows than in older animals (study 1), which may be associated with the achievement of skeletal maturity.
As in humans (Cross et al., 1995) , levels of the bone resorption marker, CL, in these studies increased during late gestation and lactation, indicating that maternal skeletal Ca stores were mobilized during the time of rapid fetal accretion of Ca (Kovacs and Kronenberg, 1997) . In study 1, circulating levels of CL were less during the first lactation compared with later lactations, indicating that the extra Ca necessary for milk production was mobilized from the skeleton of first parity sows to a smaller extent than of older sows. Except for a near-significant trend for decreased CL during treatment HYD (P = 0.10) in study 2 (5 d PP), which could indicate reduced bone resorption, the CL concentrations were not different among the treatments. Nevertheless, it is probable that supplementing the diet of particularly multiparous sows with a more readily available source of vitamin D 3 may have a sparing effect on skeletal Ca stores by enhancing alternative mechanisms of Ca acquisition, such as intestinal absorption and renal resorption. Brommage and DeLuca (1984) previously reported that although milk production is reduced in vitamin D-deficient rats, no severe deficiency in any essential nutrient other than vitamin D 3 could be detected. Even though the transfer of vitamin D 3 metabolites into breast milk is rather limited (Hollis and Wagner, 2004) , milk 25-OH-D 3 concentrations were found to correspond with maternal plasma 25-OH-D 3 concentrations and maternal vitamin D 3 intake (Specker et al., 1985) . Consistent with that, sows receiving 25-OH-D 3 as the vitamin D 3 source (i.e., treatment HD in study 1) secreted greater concentrations of 25-OH-D 3 into their milk but not into their colostrum. This is consistent with observations in rats where, during the very early stages of lactation, the vitamin was present mainly in the form of vitamin D 3 (not determined in our study), which declined within several days so that the predominant metabolite was 25-OH-D 3 (Clements and Fraser, 1988) . Because of reported cases of rickets in piglets due to a lack of vitamin D in the milk (Hartmann and Holmes, 1989) , enhancing vitamin D 3 content of milk by supplementing the sow's diet might be a possible strategy to help maintain Ca homeostasis in the suckling piglet.
The reproductive performance of the animals was not substantially affected by dietary treatment in study 1. Even when offered the minimum vitamin D 3 supplementation (i.e., DL group) over a period of 4 parities, sows were able to reproduce and numbers of live and dead born piglets as well as piglet birth weights were similar among the 3 treatment groups. Results from experiments in rats (Gray et al., 1979; Halloran and DeLuca, 1980) and humans (Kovacs and Kronenberg, 1997) confirmed that vitamin D 3 is not directly necessary for reproduction because, due to homeorhetic mechanisms, the fetal-placental unit is able to meet its needs, irrespective of maternal Ca or vitamin D 3 levels. Moreover, because only maternal 25-OH-D 3 but not 1,25-(OH) 2 -D 3 crosses the placenta (Haddad et al., 1971) , circulating levels of 1,25-(OH) 2 -D 3 in the fetus must be derived from fetal sources. At parturition, Ca metabolism of the fetus undergoes substantial changes. After cutting of the umbilical cord, the placental Ca infusion is abruptly lost and, therefore, the adaptive goals of the neonate are to quickly turn on parathyroid hormone and 1,25-(OH) 2 -D 3 synthesis, which in turn upregulates intestinal Ca absorption (Kovacs and Kronenberg, 1997) . Therefore, the importance of vitamin D 3 in maintaining normal neonatal weight gain, plasma mineral concentrations, and normal skeletal development is negligible before the suckling period and increases progressively during the later stages of lactation (Brommage and Neuman, 1981; DeLuca, 1979, 1981) . It was therefore concluded that the growth retardation of DL progeny in the present study probably was not started until the later stages of lactation, when vitamin D 3 -mediated Ca transport mechanisms become activated. It has been shown previously that growth of piglets is predominantly limited by the amount of milk produced by the sow (Pluske and Dong, 1998) , which has been shown to be significantly correlated with the size of the litter suckled, the litter weight at weaning, and the change in weight of the sows during lactation. It is therefore concluded that differences in piglet growth rate are in the first line caused by differences in the amount of milk produced by their dam. Brommage and DeLuca (1984) reported reduced milk production and, thus, retarded pup growth in vitamin D-deficient rats. The results of the field trial (i.e., study 2) indicated an interesting effect of the dietary source of vitamin D 3 on the productivity of sows. Although there were no differences among the treatments in the number of piglets born alive per farrowed sow, the total litter weight and the birth weight per piglet were significantly increased in sows supplemented with 25-OH-D 3 (HYD) when compared with the controls (CON) fed an equivalent level of vitamin D 3 . It is suggested that maternal 25-OH-D 3 beneficially supported the intrauterine development of the embryos.
SUMMARY AND CONCLUSIONS
In summary, the supplementation of the diet of sows during gestation and lactation with 25-OH-D 3 clearly improved blood vitamin D 3 status and also 25-OH-D 3 content of milk. Accordingly, minimum maternal supply with vitamin D 3 resulted in decreased concentration of 25-OH-D 3 in blood and milk. These results indicate that an adequate vitamin D 3 supplementation of the sow helps to maintain maternal Ca homeostasis during periods of strong demand such as gestation and lactation. Furthermore, supplementation of the sow with 25-OH-D 3 improved birth weight of the piglets, but the gestational vitamin D 3 status of the mother had no influence on neonatal development. Although milk concentration of 25-OH-D 3 increased when 25-OH-D 3 was fed, the greater vitamin D 3 content did not markedly influence piglet growth. The tendency towards diminished bone turnover in multiparous sows receiving 25-OH-D 3 is promising.
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